MedTrace Logo

Evaluation of a New CZT System

NCT01084356 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-03-10

No results posted yet for this study

Summary

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Conditions

  • Parathyroid Adenoma
  • Thyroid Adenoma

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Einat Even Sapir, PhD, MD · Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084356 on ClinicalTrials.gov